Position in ALNY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,276,432
-$423,907 QoQ
Shares Held
14,206
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#251
of 780 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LBP AM SA holds $68,103,102 across 9 Biotechnology names. ALNY ranks #4 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
388,498 | $36,149,738 | |
| 2 | INCY |
Incyte Corp
|
95,697 | $10,848,211 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,597 | $7,747,497 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
14,206 | $4,276,432 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
93,906 | $3,663,273 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
17,947 | $2,057,982 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,005 | $1,873,737 | |
| 8 | RPRX |
Royalty Pharma plc
|
22,589 | $1,266,565 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,276,432 | 14,206 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $4,700,339 | 14,206 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,097,693 | 7,790 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,731,904 | 8,184 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,713,720 | 8,322 | Shares | Sole | 2025-07-18 | |
| 2023-03-31 | $508,011 | 2,536 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $644,982 | 2,714 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||